Target intelligence / Profile preview

UBTF like 9 (pseudogene) (UBTFL9)

Target: UBTFL9
Molecular classification: Other (Pseudogene)

Overview

UBTFL9 (UBTF like 9) is a pseudogene classified as "upstream binding transcription factor, RNA polymerase I-like 9 (pseudogene)". Pseudogenes are genomic sequences similar to normal genes but are typically nonfunctional; they arise from gene duplications or retrotransposition events. UBTFL9 does not encode a protein product, is not functionally characterized, and is not considered a therapeutic target[1].

Other names: UBTF like 9UBTFL9upstream binding transcription factor, RNA polymerase I pseudogeneupstream binding transcription factor, RNA polymerase I-like 9 (pseudogene)

Beyond the preview

Go deeper on UBTF like 9 (pseudogene) (UBTFL9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBTF like 9 (pseudogene) (UBTFL9).

Explore the full profile